Chronic Kidney Disease

Well-Studied

Overview

Chronic Kidney Disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to filter blood, regulate fluid balance, maintain electrolyte levels, and support functions such as blood pressure control, red blood cell production, and bone-mineral metabolism. In conventional medicine, CKD is typically defined by abnormalities of kidney structure or function that persist for more than three months, often identified by a reduced estimated glomerular filtration rate (eGFR), elevated urine albumin, or imaging and laboratory findings that suggest ongoing kidney damage. Because the kidneys affect many systems at once, CKD is not only a renal disorder but also a major cardiometabolic and public health issue.

CKD is common worldwide and often progresses silently. Early stages may cause few or no noticeable symptoms, while more advanced disease can be associated with fatigue, swelling, changes in urination, poor appetite, itching, sleep disturbance, anemia, bone disease, and cardiovascular complications. Major risk factors include diabetes, high blood pressure, cardiovascular disease, obesity, older age, autoimmune disease, recurrent kidney injury, inherited kidney disorders, and exposure to nephrotoxic medications or toxins. Research consistently shows that CKD is linked with a higher risk of heart attack, stroke, hospitalization, and premature mortality.

The condition is usually described in stages based on eGFR and albuminuria, which together help estimate severity and risk of progression. Some people remain stable for years, while others experience gradual decline toward kidney failure, at which point dialysis or kidney transplantation may become necessary. Studies indicate that earlier detection and risk-factor management are associated with slower progression and better overall outcomes, particularly when blood pressure, blood sugar, and cardiovascular risk are addressed in a coordinated way.

From a broader health perspective, CKD is significant because it affects quality of life, medication metabolism, nutrition, and the safety of many common therapies. It also frequently coexists with frailty, inflammation, mineral imbalance, and psychosocial burden. For that reason, both conventional and traditional systems often view CKD as a complex, whole-person condition that benefits from individualized evaluation by qualified healthcare professionals, especially because symptoms and laboratory changes do not always move together.

Western Medicine Perspective

Western Medicine Perspective

In conventional medicine, CKD is understood as a chronic loss of nephron function caused by ongoing damage to the kidney's filtering units, blood vessels, tubules, or supporting tissues. Common underlying causes include diabetic kidney disease, hypertensive kidney damage, glomerulonephritis, polycystic kidney disease, obstructive uropathy, and autoimmune or inflammatory disorders. Diagnostic evaluation generally focuses on repeated measures of serum creatinine, eGFR, urine albumin-to-creatinine ratio, urinalysis, blood pressure, metabolic panels, and sometimes kidney imaging or biopsy. Clinical assessment also looks for complications such as anemia, acidosis, potassium imbalance, fluid overload, chronic kidney disease–mineral and bone disorder (CKD-MBD), and cardiovascular disease.

Modern management is centered on risk stratification and slowing progression, while also reducing complications and preserving quality of life. Research supports the importance of identifying reversible contributors such as dehydration, medication-related kidney injury, urinary obstruction, uncontrolled blood pressure, and poorly controlled diabetes. Contemporary nephrology also places strong emphasis on cardiovascular protection, since people with CKD are often more likely to experience cardiovascular events than to progress immediately to kidney failure. Care plans are typically individualized based on CKD stage, albuminuria, cause of disease, comorbidities, and overall functional status.

Evidence-based care may involve monitoring kidney function over time, adjusting medication dosing for renal function, addressing blood pressure and glycemic control, evaluating dietary factors, and planning ahead for advanced care needs when disease progresses. In later stages, clinicians may discuss renal replacement therapies such as dialysis or transplantation, as well as supportive and palliative models of care. Because CKD is complex and often changes the safety profile of common drugs, conventional medicine generally emphasizes ongoing follow-up with primary care clinicians, nephrologists, and other specialists as appropriate.

Eastern & Traditional Perspective

Eastern / Traditional Medicine Perspective

In Traditional Chinese Medicine (TCM), chronic kidney disorders are not framed solely as reduced filtration capacity but as patterns of imbalance involving the Kidney system, often in relationship with the Spleen, Liver, and Lung. Depending on presentation, practitioners may describe patterns such as Kidney Yin deficiency, Kidney Yang deficiency, Spleen-Kidney deficiency, dampness accumulation, blood stasis, or toxin retention. Symptoms such as edema, low back weakness, fatigue, urinary changes, coldness, night sweats, or dryness may be interpreted through these pattern frameworks rather than through laboratory markers alone. Traditional assessment typically considers the whole symptom picture, pulse, tongue findings, digestion, sleep, and constitutional tendencies.

Within Ayurveda, kidney-related chronic disease may be understood through disturbances in doshas, impaired tissue metabolism, fluid balance, and accumulation of metabolic waste, sometimes discussed in relation to mutravaha srotas (urinary channels). Broader traditional systems often emphasize the interconnected roles of digestion, circulation, inflammation, vitality, and elimination. Naturopathic and integrative frameworks may similarly view CKD as involving systemic burden, oxidative stress, metabolic dysfunction, and reduced resilience, while recognizing the importance of conventional laboratory monitoring and specialist care.

Traditional and integrative approaches have historically used dietary frameworks, mind-body practices, acupuncture, and botanical formulations in support of symptom relief and overall balance. However, the evidence base for many complementary interventions in CKD remains mixed or limited, and some herbs or supplements may carry important safety concerns because reduced kidney function can alter clearance and increase the risk of toxicity, contamination, electrolyte disturbance, or herb-drug interactions. For that reason, integrative care models generally stress coordination with qualified healthcare professionals, especially nephrology-informed clinicians, before combining traditional therapies with standard CKD care.

Related Topics

Anemia

Anemia β€” a condition in the health ontology.

How They Relate

Condition / Condition

Chronic Kidney Disease & Anemia

Chronic kidney disease (CKD) and anemia are closely linked. As kidney function declines, damaged peritubular fibroblasts in the kidney produce less erythropoietin (EPO), the hormone that stimulates...

Supplements & Products

Evidence & Sources

Well-Studied

Supported by multiple clinical trials and systematic reviews

  1. KDIGO Clinical Practice Guidelines
  2. National Kidney Foundation
  3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  4. The Lancet
  5. New England Journal of Medicine
  6. JAMA
  7. Nature Reviews Nephrology
  8. World Health Organization (WHO)
  9. National Center for Complementary and Integrative Health (NCCIH)

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.